Litigation Details for DUKE UNIVERSITY v. AKORN, INC. (D.N.J. 2018)

DUKE UNIVERSITY v. AKORN, INC. (D.N.J. 2018)

Docket	3:18-cv-14035	Date Filed	2018-09-19
Court	District Court, D. New Jersey	Date Terminated	2019-10-15
Cause	35:271 Patent Infringement	Assigned To	Brian R. Martinotti
Jury Demand	Both	Referred To	Tonianne J. Bongiovanni
Patents	4,599,353; 7,351,404; 7,388,029; 8,038,988; 8,101,161; 8,263,054; 8,906,962; 8,926,953; 9,579,270
Link to Docket	External link to docket

Details for DUKE UNIVERSITY v. AKORN, INC. (D.N.J. 2018)

Date Filed	Document No.	Description	Snippet	Link To Document
2018-09-19				External link to document
2018-09-19	1		litigated other patents that cover LATISSE®, including U.S. Patent No. 7,388,029 (“the ’029 patent’), to which…infringement of U.S. Patent Nos. 9,579,270 (“the ’270 patent”) under the Patent Laws of the United States…exclusive license to the ’270 patent. 21. The ’270 patent has a patent term that expires on January…United States Patent and Trademark Office (“USPTO”) duly and legally issued the ’270 patent, entitled “…the ’270 patent is attached to this complaint as Exhibit A. 19. The ’270 patent is assigned	External link to document
2018-09-19	22	Brief	following patents owned by Allergan that cover LATISSE®: Patent Nos. 7,351,404 (“’404 patent”); 8,038,988…988 patent”); 8,101,161 (“’161 patent”); 8,263,054 (“’054 patent”); and 8,926,953 (“’953 patent”). …litigated other patents that cover LATISSE®, including U.S. Patent No. 7,388,029 (“’029 patent”). The asserted…antitrust and patent misuse counterclaims is that Plaintiffs’ current and prior patent infringement …legal monopolies by the U.S. Patent and Trademark Office (“USPTO”). Once a patent issues, the First Amendment	External link to document